Light Mode
$112.58 ↑ +0.00 (+0.00%) Trading Up from the previous close of $112.58, $3.79 below the day’s high of $116.37
-20.68 (-15.52%) / 6M
Momentum, market sentiment, and recent alerts
INSM reads very good: price sits above one of the two key moving averages, the 12-month move is -39.5%.
No alerts for INSM in the last day.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
Insmed, Inc. is a global biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases. Its focuses on Brensocatib, and Treprostinil Palmitil Inhalation Powder (TPIP) pipeline. The company was founded in 1988 and is headquartered in Bridgewater, NJ.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.